JPRN-UMIN000037584已完成未知
rodynamic efficacy of fesoterodine for the treatment of neurogenic detrusor overactivity and/or low-compliance bladder - tolterodine for neurogenic detrusor overactivity
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 77
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •With an indwelling catheter, other genitourinary tract anomalies, acute infection of the genitourinary tract diseases
研究者
相似试验
已完成
不适用
The persistence of fesoterodine and the reasons for withdrawal from treatment of treatment-naive female patients with overactive bladder in the real-world clinical settingOveractive bladderJPRN-UMIN000038603Hokkaido Prefectural Esashi Hospital100
尚未招募
不适用
Objective assessment of fesoterodine for overactive bladder with benign prostatic hyperplasiaOveractive bladder associated with benign prostatic hyperplasiaJPRN-UMIN000010296Dept. of Urology, Kyoto University Graduate School of Medicine40
已完成
4 期
Fesoterodine fumarate for the treatment of neurogenic bladdereurogenic detrusor overactivity (NDO)Nervous System DiseasesNeurogenic detrusor overactivity (NDO)ISRCTN22433402ational Rehabilitation Center85
已完成
3 期
Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine Extended Release(ER)in Patients With Overactive Bladder.Overactive BladderNCT00611026Pfizer2,417
已完成
3 期
Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)Overactive BladderNCT00444925Pfizer1,712